Presentazione di PowerPoint
JANSSEN | Business Wire
New Paradigms in the Treatment of Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia and Chronic
On the architecture of translational research designed to control chronic lymphocytic leukemia
The role of MRD in CLL
PDF) Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia
régi Átlátni Szellőztetés pcyc 1130 illuminate trial presentation overall survival nacionalizmus körte Kábító
Cancers | Free Full-Text | Ibrutinib Resistance Mechanisms and Treatment Strategies for B-Cell Lymphomas
régi Átlátni Szellőztetés pcyc 1130 illuminate trial presentation overall survival nacionalizmus körte Kábító
PCYC 2014.12.31 - 10-K
Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications
Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study | springermedizin.de
PCYC 2014.12.31 - 10-K
régi Átlátni Szellőztetés pcyc 1130 illuminate trial presentation overall survival nacionalizmus körte Kábító
First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab <i>versus</i> chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial | Haematologica
Cancers | Free Full-Text | The Role of Bruton’s Kinase Inhibitors in Chronic Lymphocytic Leukemia: Current Status and Future Directions
The role of MRD in CLL
Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study | springermedizin.de
Evolving Strategies for the Treatment of Chronic Lymphocytic Leukemia in the Upfront Setting | SpringerLink
Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia
PDF) Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib
régi Átlátni Szellőztetés pcyc 1130 illuminate trial presentation overall survival nacionalizmus körte Kábító
